Labshake search
Citations for TriLink BioTechnologies :
1 - 23 of 23 citations for 6 Methyl 4 trifluoromethyl nicotinonitrile since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Immunology 2021Quote: ... N1-methyl-pseudouridine (Trilink) and 5-Methylcytidine (Trilink) ...
-
bioRxiv - Cancer Biology 2019Quote: 2’O-methyl SSOs were provided by Trilink BioTechnologies ...
-
bioRxiv - Bioengineering 2023Quote: ... 12.5 mM N1-methyl-pseudo-UTP (TriLink Biotechnologies), and 10 mM CleanCap AG (TriLink Biotechnologies) ...
-
bioRxiv - Developmental Biology 2021Quote: ... PCR product synthesized with N4-methyl-dCTP (4mdCTP; Trilink) using primers JZ294/JZ295 (Table S5 ...
-
bioRxiv - Molecular Biology 2019Quote: ... and 2’ O-methyl phosphorothioate AOs were synthesised by TriLink BioTechnologies (San Diego CA ...
-
bioRxiv - Immunology 2024Quote: ... Methyl-pseudouridine (SYNTHGENE)-modified mRNAs were capped using Cap1 Analogue Reagent (TriLink) and further purified by Monarch RNA purification columns (NEB ...
-
bioRxiv - Immunology 2023Quote: ... mRNAs were modified with N1-Methyl-pseudouridine (Synthgene) and capped using CleanCap Reagent (TriLink). After this ...
-
bioRxiv - Immunology 2023Quote: ... with substitution of N-1-methyl-pseudouridine-5’-triphosphate (TriLink Biotechnologies, #N-1081-1) for UTP and co-transcriptional capping with CleanCap® Reagent AG (TriLink Biotechnologies ...
-
bioRxiv - Biophysics 2020Quote: ... except each nucleotide was present at a final concentration of 4 mM and the reaction was supplemented with 6 mM of 5’-biotin-G-Monophosphate (Trilink, #N-6003). Reactions were incubated at 37 °C for 2 hours ...
-
bioRxiv - Microbiology 2022Quote: ... for co-transcriptional capping of mRNA and complete replacement of uridine by N1-methyl-pseudouridine (Trilink, CA, USA). The mRNA was purified by LiCl (Invitrogen ...
-
bioRxiv - Genomics 2020Quote: ... The NEB HiScribe High-Yield Kit was used as per the instruction manual but with full substitution of N1-methyl-pseudouridine for uridine and co-transcriptional capping with CleanCap AG (Trilink). Reaction cleanup was performed by lithium chloride precipitation ...
-
bioRxiv - Genomics 2021Quote: ... was used according to the company’s recommended instruction but with full substitution of N1-methyl-pseudouridine for uridine and co-transcriptional capping with CleanCap AG (TriLink Biotechnologies). RNA was precipitated with lithium chloride (2.5 M final concentration) ...
-
bioRxiv - Synthetic Biology 2021Quote: ... 6 mM Anti Reverse Cap Analog (TriLink BioTechnologies), and the template DNA ...
-
bioRxiv - Physiology 2021Quote: ... and CleanCap® Reagent AG (6 mM, N-7113, TriLink Biotechnologies, USA) (Zangi et al. ...
-
bioRxiv - Genomics 2022Quote: ... 4 mM CleanCap AG (TriLink, N-7113), 1 unit/μL Murine RNase Inhibitor (NEB ...
-
bioRxiv - Molecular Biology 2021Quote: ... and phosphorylated 4-thiouridine (TriLink, N-1025). Different strands of pre-mRNA were generated for each construct that included different quantities of 4sU ...
-
bioRxiv - Immunology 2019Quote: ... Mouse C57BL/6 zygotes (Taconic) were injected with a mix of Cas9 mRNA (Trilink Biotechnologies) (100 ng/uL ...
-
bioRxiv - Bioengineering 2019Quote: ... 6 μg of Cas9 (Integrated DNA Technologies, IA, Cat: 1074182) and 3.2 μg of MS-sgRNA (Trilink Biotechnologies, CA) (molar ratio = 1:2.5 ...
-
bioRxiv - Neuroscience 2021Quote: ... which were then plated at 500,000 cells per well in a Matrigel-coated 6-well plate for transfection with 1.2 ug of Cre recombinase mRNA (TriLink Biotechnologies cat. no. L-7211) using Lipofectamine Stem to remove the puromycin resistance gene and mCherry ...
-
bioRxiv - Synthetic Biology 2023Quote: ... along with 500 ng of linear template and 4 mM CleanCap AG Reagent (Trilink, N-7113). 5 mM N1-Methylpseudouridine-5’-triphosphate (Trilink ...
-
bioRxiv - Bioengineering 2023Quote: ... An organic phase containing a mixture of lipids dissolved in ethanol at a designated molar ratio (Fig 1C and Supp Table 1) was mixed with an aqueous phase (50 mM citrate buffer, pH 4) containing Luciferase mRNA (TriLink) at a flow rate ratio of 1:3 and at a total lipid/mRNA weight ratio of 40:1 in a microfluidic mixing device (NanoAssemblr Ignite ...
-
bioRxiv - Bioengineering 2023Quote: ... All saRNA templates were generated from a plasmid encoding NSP1-4 of the Venezuela Equine Encephalitis Virus (VEEV) under either a CleanCap AU (TriLink BioTechnologies) compatible T7 promoter (Promoter seq ...
-
bioRxiv - Bioengineering 2023Quote: ... was mixed with an aqueous phase (50 mM citrate buffer, pH 4) containing Luciferase mRNA that was either purchased by TriLink (most experiments) or made in-house via in vitro transcription (IVT)40 at a flow rate ratio of 1:3 and at a total lipid/mRNA weight ratio of 40:1 in a microfluidic mixing device (NanoAssemblr Ignite ...